InvestSMART

Aroa Biosurgery Limited (ASX: ARX) - Announcements

Current share price for ARX : $0.565 0.01 (1.74%)+

ASX company news and announcements for Aroa Biosurgery Limited (ARX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Aroa Biosurgery Limited (ARX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Aroa Biosurgery Limited (ARX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Aroa Biosurgery Limited (ARX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$195 Notification of Quarterly Results Webinar 23 Apr 2024 8:44AM $0.500 $0.565 risen by 13%
$195 Notification of cessation of securities - ARX 8 Apr 2024 4:10PM $0.565 $0.565 fallen by 0%
$195 Final Director's Interest Notice - SE 4 Apr 2024 9:55AM $0.545 $0.565 risen by 3.67%
$195 Change of Director's Interest Notice - SE 28 Mar 2024 10:16AM $0.565 $0.565 fallen by 0%
$195 Application for quotation of securities - ARX 28 Mar 2024 10:13AM $0.565 $0.565 fallen by 0%
$195 Section 708A Notice 28 Mar 2024 10:10AM $0.565 $0.565 fallen by 0%
$195 Initial Director's Interest Notice - DH 22 Mar 2024 9:41AM $0.535 $0.565 risen by 5.61%
$195 Intuitive's Darla Hutton joins Board, Steven Engle retires 22 Mar 2024 9:37AM $0.535 $0.565 risen by 5.61%
$195 Change of Director's Interest Notice - PM 23 Feb 2024 4:18PM $0.575 $0.565 fallen by 1.74%
$195 Change in substantial holding 20 Feb 2024 3:12PM $0.590 $0.565 fallen by 4.24%
$195 Notification of cessation of securities - ARX 14 Feb 2024 2:13PM $0.570 $0.565 fallen by 0.88%
$195 Application for quotation of securities - ARX 14 Feb 2024 2:12PM $0.570 $0.565 fallen by 0.88%
$195 Section 708A Notice 14 Feb 2024 2:10PM $0.570 $0.565 fallen by 0.88%
$195 Investor Presentation 30 Jan 2024 8:44AM $0.720 $0.565 fallen by 21.53%
$195 December 2023 Quarterly Report and Appendix 4C 30 Jan 2024 8:43AM $0.720 $0.565 fallen by 21.53%
$195 Enivo Clinical Pilot Study 25 Jan 2024 12:53PM $0.740 $0.565 fallen by 23.65%
$195 Notification of Quarterly Results Webinar 23 Jan 2024 9:07AM $0.690 $0.565 fallen by 18.12%
$195 Notification of cessation of securities - ARX 12 Jan 2024 12:36PM $0.785 $0.565 fallen by 28.03%
$195 Aroa Half Year Results Presentation 28 Nov 2023 9:07AM $0.720 $0.565 fallen by 21.53%
$195 Aroa Biosurgery Half Yearly Results H1 FY24 28 Nov 2023 9:04AM $0.720 $0.565 fallen by 21.53%
$195 Appendix 4D and Half Year Report 28 Nov 2023 9:01AM $0.720 $0.565 fallen by 21.53%
$195 Notification of Half Year Results Webinar 22 Nov 2023 9:01AM $0.670 $0.565 fallen by 15.67%
$195 AROA Investor Event 21 Nov 2023 8:50AM $0.685 $0.565 fallen by 17.52%
$195 Bell Potter Healthcare Conference Presentation 14 Nov 2023 9:19AM $0.735 $0.565 fallen by 23.13%
$195 Investor Presentation 31 Oct 2023 8:34AM $0.745 $0.565 fallen by 24.16%

126 - 150 of 762 results

Page 6 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.